![closeup_By_Jean-Etienne_Minh-Duy_Poirrier_from_Bruxelles_Belgium_[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons closeup_By_Jean-Etienne_Minh-Duy_Poirrier_from_Bruxelles_Belgium_[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons](../news/img/healthcare/closeup_By_Jean-Etienne_Minh-Duy_Poirrier_from_Bruxelles_Belgium_[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons.jpg)
For the most recent fiscal period AMGN profits were up by 20.24 % of $3.98 per share compare to $3.31 a year before and earnings per share soared by 62.45 % from $2.45 per share from the prior reporting period.
Revenues remained unaffected to $
0.00 millions from $0.00 millions in the similar reporting period a year before and sequentially from $0.00 millions.
Net profits of $2,143.000 millions in the most recent fiscal period increased by 13.75 % from net earnings of $1,884.000 millions reported in the most recent fiscal period a year ago.
Amgen Inc is expected to report next financial recent numbers on February 15, 2023.